CTT PHARMACEUTICAL HOLDINGS, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CTT PHARMACEUTICAL HOLDINGS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | ($672.2K) | Oct 8, 2015 |
| FY2014 | Dec 31, 2013 | ($18.9K) | Oct 8, 2015 |
| FY2013 | Dec 31, 2012 | ($1.00M) | Feb 10, 2014 |
| FY2012 | Dec 31, 2011 | $3.74M | Mar 8, 2013 |
| FY2011 | Dec 31, 2010 | ($1.10M) | Mar 20, 2012 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | ($672.2K) | Oct 8, 2015 |
| FY2014 | Dec 31, 2013 | ($18.9K) | Oct 8, 2015 |
| FY2013 | Dec 31, 2012 | ($1.19M) | Feb 10, 2014 |
| FY2012 | Dec 31, 2011 | ($757.9K) | Mar 8, 2013 |
| FY2011 | Dec 31, 2010 | ($2.07M) | Mar 20, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | ($72.3K) | Oct 8, 2015 |
| FY2014 | Dec 31, 2013 | ($209) | Oct 8, 2015 |
| FY2013 | Dec 31, 2012 | ($1.03M) | Feb 10, 2014 |
| FY2012 | Dec 31, 2011 | ($316.1K) | Mar 8, 2013 |
| FY2011 | Dec 31, 2010 | ($1.67M) | Mar 20, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $1.66M | Oct 8, 2015 |
| FY2013 | Dec 31, 2013 | $6.3K | Feb 10, 2014 |
| FY2013 | Dec 31, 2012 | $203.1K | Feb 10, 2014 |
| FY2012 | Dec 31, 2011 | $4.18M | Mar 8, 2013 |
| FY2011 | Dec 31, 2010 | $1.26M | Mar 20, 2012 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $169.5K | Oct 8, 2015 |
| FY2014 | Dec 31, 2013 | $29.3K | Oct 8, 2015 |
| FY2013 | Dec 31, 2012 | $589.4K | Feb 10, 2014 |
| FY2012 | Dec 31, 2011 | $3.73M | Mar 8, 2013 |
| FY2011 | Dec 31, 2010 | $1.26M | Mar 20, 2012 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $1.49M | Oct 8, 2015 |
| FY2014 | Dec 31, 2013 | ($29.3K) | Oct 8, 2015 |
| FY2014 | Dec 31, 2012 | ($20.0K) | Oct 8, 2015 |
| FY2013 | Dec 31, 2011 | $456.5K | Feb 10, 2014 |
| FY2013 | Dec 31, 2010 | $1.3K | Feb 10, 2014 |
| FY2013 | Dec 31, 2009 | ($1.25M) | Feb 10, 2014 |
| FY2013 | Dec 31, 2008 | $151.4K | Feb 10, 2014 |
| FY2013 | Dec 31, 2007 | $557.9K | Feb 10, 2014 |
| FY2013 | Dec 31, 2006 | $765.0K | Feb 10, 2014 |
| FY2013 | Dec 31, 2005 | $74.2K | Feb 10, 2014 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | ($867.4K) | Oct 8, 2015 |
| FY2014 | Dec 31, 2013 | ($195.2K) | Oct 8, 2015 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $81.2K | Oct 8, 2015 |
| FY2013 | Dec 31, 2013 | $823 | Feb 10, 2014 |
| FY2013 | Dec 31, 2012 | $12.1K | Feb 10, 2014 |
| FY2013 | Dec 31, 2011 | $569.4K | Feb 10, 2014 |
| FY2012 | Dec 31, 2010 | $46.2K | Mar 8, 2013 |
| FY2011 | Dec 31, 2009 | $271.2K | Mar 20, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | 0 | Feb 10, 2014 |
| FY2013 | Dec 31, 2012 | 0 | Feb 10, 2014 |
| FY2012 | Dec 31, 2011 | 0 | Mar 8, 2013 |
| FY2011 | Dec 31, 2010 | 0 | Mar 20, 2012 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | 0 | Feb 10, 2014 |
| FY2013 | Dec 31, 2012 | 0 | Feb 10, 2014 |
| FY2012 | Dec 31, 2011 | 0 | Mar 8, 2013 |
| FY2011 | Dec 31, 2010 | 0 | Mar 20, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | 19.51M | Oct 8, 2015 |
| FY2014 | Dec 31, 2013 | 14.92M | Oct 8, 2015 |
| FY2013 | Dec 31, 2012 | 9.30M | Feb 10, 2014 |
| FY2012 | Dec 31, 2011 | 9.30M | Mar 8, 2013 |
| FY2011 | Dec 31, 2010 | 163.25M | Mar 20, 2012 |